세계의 비경구용 생리 식염수 시장 예측(-2032년) : 유형별, 용기 유형별, 용량별, 용도별, 최종 용도별, 지역별 분석

According to Stratistics MRC, the Global Normal Saline for Parenteral Use Market is accounted for $3.6 billion in 2025 and is expected to reach $6.4 billion by 2032 growing at a CAGR of 7.5% during the forecast period. Normal Saline for Parenteral Use is a sterile, isotonic solution of 0.9% sodium chloride in water, used for intravenous (IV) therapy. It restores fluid balance, maintains blood pressure, and delivers medications in clinical settings. As a physiological equivalent to blood plasma, it minimizes cellular damage during infusion. Normal saline is a cornerstone of emergency medicine, surgery, and dehydration treatment, ensuring safe and effective patient care in hospitals and ambulances worldwide.

According to the National Center for Biotechnology Information, in the U.S., around 200 million liters of saline are sold annually. In addition, over 1 million liters of 0.9% sodium chloride are administered to patients across the globe daily.

Market Dynamics:

Driver:

Increasing surgical procedures globally

The rising number of surgical procedures worldwide is fueling demand for normal saline as a critical intravenous fluid. Growing prevalence of chronic diseases requiring surgical interventions drives market growth. Advancements in minimally invasive surgeries increase the need for reliable hydration solutions. Expanding healthcare infrastructure in emerging markets supports higher surgical volumes. Government initiatives to improve access to surgical care enhance market potential. The aging global population contributes to increased surgical needs.

Restraint:

Stringent regulatory requirements

Stringent regulations governing the production and distribution of parenteral saline solutions increase compliance costs. Complex approval processes for manufacturing facilities delay market entry. Strict quality control standards require significant investment in technology. Regulatory variations across regions complicate global supply chains. Non-compliance risks product recalls, damaging brand reputation. Limited flexibility in formulation adjustments hinders innovation.

Opportunity:

Development of innovative packaging solutions

Innovations in packaging, such as eco-friendly and tamper-proof designs, are creating opportunities for market expansion. Advanced packaging enhances product safety and shelf life, appealing to healthcare providers. The demand for portable and user-friendly saline delivery systems is rising. Partnerships with packaging technology firms drive product development. Regulatory support for sustainable packaging encourages investment. The trend toward single-use, sterile packaging boosts market appeal. These advancements improve accessibility and adoption in diverse healthcare settings.

Threat:

Raw material price fluctuations

Fluctuations in the prices of raw materials, such as sodium chloride and sterile water, impact production costs. Supply chain disruptions exacerbate price volatility, affecting profitability. Dependence on limited suppliers increases vulnerability to market shocks. Rising energy costs for sterilization processes add financial strain. Unpredictable pricing complicates long-term contracts with healthcare providers. Lack of diversified sourcing strategies heightens risks.

Covid-19 Impact:

The COVID-19 pandemic surged demand for normal saline due to increased hospitalizations and critical care needs. Supply chain disruptions delayed raw material deliveries, impacting production. The rise in telehealth reduced non-emergency saline use in outpatient settings. However, vaccination campaigns and emergency care boosted market demand. Rising manufacturing costs during the crisis affected affordability. The pandemic underscored the importance of reliable IV fluids, driving investments. Post-pandemic recovery in surgical procedures is expected to sustain market growth.

The plastic bottles segment is expected to be the largest during the forecast period

The plastic Bottles segment is expected to account for the largest market share during the forecast period propelled by their widespread use in hospitals for safe and convenient saline delivery. Plastic bottles offer durability and ease of handling, enhancing operational efficiency. Advances in sterile manufacturing ensure product safety and compliance. The cost-effectiveness of plastic bottles drives adoption in budget-conscious markets. Regulatory approvals for medical-grade plastics bolster market trust. Their versatility across surgical and emergency applications strengthens market share.

The flexible bags segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the flexible bags segment is predicted to witness the highest growth rate driven by their lightweight design and space-saving benefits in healthcare settings. Flexible bags reduce storage and transportation costs, appealing to hospitals. Innovations in tamper-proof and eco-friendly bag designs enhance adoption. The rise in outpatient and home care increases demand for portable saline solutions. Regulatory support for sustainable packaging fuels segment expansion. Partnerships with logistics firms optimize distribution efficiency. The focus on patient convenience propels this segment's growth.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to its robust healthcare sector and high surgical volumes in countries like China and India. Rapid population growth and rising chronic diseases drive demand for saline. Government investments in healthcare infrastructure support market growth. The presence of key manufacturers strengthens regional dominance. Increasing access to surgical care fuels saline use. Rising disposable incomes enhance healthcare spending.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR fueled by advanced healthcare systems and stringent regulatory standards. The region's high surgical procedure rates drive demand for reliable saline solutions. Innovations in packaging and delivery systems enhance market growth. The presence of leading pharmaceutical companies fosters product development. Growing awareness of patient safety boosts adoption. Investments in outpatient care infrastructure support expansion.

Key players in the market

Some of the key players in Normal Saline for Parenteral Use Market include Baxter, Pfizer, B. Braun, ICU Medical, Fresenius Kabi, Otsuka, Kelun Group, CR Double-Cran, SSY Group, Cisen Pharmaceutical, Denis Chem Lab Limited, Advacare Pharma USA, LLC., NIRMA LIMITED, Alcare Pharmaceuticals Pte Ltd, and Sichuan Kelun Pharmaceutical Co., Ltd.

Key Developments:

In April 2025, Baxter International expanded production of FDA-approved electrolyte-enriched saline solutions with improved stability for critical care, addressing global IV fluid shortages in emergency medicine.

In March 2025, Fresenius Kabi launched premixed saline bags with pH-balancing additives for chemotherapy patients, reducing side effects and simplifying oncology infusion protocols in hospitals.

In February 2025, Kelun Group debuted China's first biodegradable saline IV packaging, cutting plastic waste by 70% while maintaining sterility standards for large-volume parenteral therapies.

Types Covered:

• Plastic Bottles
• Glass Bottles

Container Types Covered:

• Flexible Bags
• Rigid Bottles And Containers
• Pre-Filled Syringes
• IV Infusion Bottles
• Vials
• Ampoules
• Other Container Types

Volumes Covered:

• Small Volume Parenteral (SVP)
• Large Volume Parenteral (LVP)
• Other Volumes

Applications Covered:

• Intramuscular Injection
• Intravenous Injection
• Wound Irrigation/Flush

End Users Covered:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Normal Saline for Parenteral Use Market, By Type

• 5.1 Introduction
• 5.2 Plastic Bottles
• 5.3 Glass Bottles

6 Global Normal Saline for Parenteral Use Market, By Container Type

• 6.1 Introduction
• 6.2 Flexible Bags
• 6.3 Rigid Bottles And Containers
• 6.4 Pre-Filled Syringes
• 6.5 IV Infusion Bottles
• 6.6 Vials
• 6.7 Ampoules
• 6.8 Other Container Types

7 Global Normal Saline for Parenteral Use Market, By Volume

• 7.1 Introduction
• 7.2 Small Volume Parenteral (SVP)
• 7.3 Large Volume Parenteral (LVP)
• 7.4 Other Volumes

8 Global Normal Saline for Parenteral Use Market, By Application

• 8.1 Introduction
• 8.2 Intramuscular Injection
• 8.3 Intravenous Injection
• 8.4 Wound Irrigation/Flush

9 Global Normal Saline for Parenteral Use Market, By End User

• 9.1 Introduction
• 9.2 Hospitals
• 9.3 Specialty Clinics
• 9.4 Ambulatory Surgical Centers
• 9.5 Other End Users

10 Global Normal Saline for Parenteral Use Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Baxter
• 12.2 Pfizer
• 12.3 B. Braun
• 12.4 ICU Medical
• 12.5 Fresenius Kabi
• 12.6 Otsuka
• 12.7 Kelun Group
• 12.8 CR Double-Cran
• 12.9 SSY Group
• 12.10 Cisen Pharmaceutical
• 12.11 Denis Chem Lab Limited
• 12.12 Advacare Pharma USA, LLC.
• 12.13 NIRMA LIMITED
• 12.14 Alcare pharmaceuticals pte ltd
• 12.15 Sichuan Kelun Pharmaceutical Co., Ltd.